RxDoctor Payments Data

Kristofer Wagner, MD

Urology · Temple, TXNPI 1174562714

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.9% of the total across 22 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Cook Medical LLC at 30.5% of the total. That places this record below the midpoint for urology clinicians in TX, where the typical reported total is $3,394.

$1,086in general payments, 2019–2025

Across 22 payments — averaging $49.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cook Medical LLC$332
  • Boston Scientific$213
  • Photocure Inc$97
  • Olympus America Inc.$95
  • EDAP Technomed Inc$89
  • Medtronic$80
  • plus $181 from 9 others
$11,948in research payments, 2019–2025

Across 10 payments — averaging $1194.80 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$12K

What the payments were for

  • Food & beverage$1,085100%
  • Education$10%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,086 in reported general payments places this provider in the 25th percentile of 878 urology providers in Texas.

See all urology providers in Texas →

Medicare billing

Part B allowed, 2024
$105,825
Medicare patients
366
Services billed
724

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XtandiEnzalutamide27$406,631
MyrbetriqMirabegron80$55,450
Tamsulosin Hcl262$8,231
Finasteride204$5,265
Potassium Citrate ErPotassium Citrate19$3,966
Alfuzosin Hcl ErAlfuzosin Hcl56$2,192
Silodosin11$1,870
Bicalutamide18$999
Trospium Chloride11$824
Allopurinol35$802
Terazosin Hcl19$540
Desmopressin Acetate16$472
Oxybutynin Chloride26$420
Oxybutynin Chloride ErOxybutynin Chloride13$404
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst14$336

Paid to pharmacies, not to this prescriber.

Other urology in Temple

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →